Published in Nature on July 18, 1991
Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest (2004) 4.97
Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest (2002) 2.74
mTOR regulates lysosomal ATP-sensitive two-pore Na(+) channels to adapt to metabolic state. Cell (2013) 2.31
Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev (2010) 2.06
Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res (2004) 2.06
Differential structure of atrial and ventricular KATP: atrial KATP channels require SUR1. Circ Res (2008) 1.98
Mitochondrial ion channels: gatekeepers of life and death. Physiology (Bethesda) (2005) 1.94
The role of mitochondria in protection of the heart by preconditioning. Biochim Biophys Acta (2007) 1.74
Mitochondrial ion channels. Annu Rev Physiol (2007) 1.70
Multiprotein complex containing succinate dehydrogenase confers mitochondrial ATP-sensitive K+ channel activity. Proc Natl Acad Sci U S A (2004) 1.60
AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels. J Cell Physiol (2007) 1.58
Pathophysiological and protective roles of mitochondrial ion channels. J Physiol (2000) 1.52
Mitochondrial ROMK channel is a molecular component of mitoK(ATP). Circ Res (2012) 1.51
ATP-sensitive K+ channel openers prevent Ca2+ overload in rat cardiac mitochondria. J Physiol (1999) 1.49
Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria. J Physiol (2003) 1.43
Mitochondrial K(ATP) channels in cell survival and death. J Mol Cell Cardiol (2005) 1.38
The endogenous mitochondrial complex II inhibitor malonate regulates mitochondrial ATP-sensitive potassium channels: implications for ischemic preconditioning. Biochim Biophys Acta (2008) 1.33
Is mPTP the gatekeeper for necrosis, apoptosis, or both? Biochim Biophys Acta (2010) 1.32
Hypoxia-induced preconditioning in adult stimulated cardiomyocytes is mediated by the opening and trafficking of sarcolemmal KATP channels. FASEB J (2004) 1.30
Cardiac mitochondria and arrhythmias. Cardiovasc Res (2010) 1.29
K+ channels in apoptosis. J Membr Biol (2006) 1.29
KATP channels and cardiovascular disease: suddenly a syndrome. Circ Res (2013) 1.23
Is Kir6.1 a subunit of mitoK(ATP)? Biochem Biophys Res Commun (2007) 1.19
Cardiac sarcolemmal K(ATP) channels: Latest twists in a questing tale! J Mol Cell Cardiol (2009) 1.17
Volatile anesthetic-induced cardiac preconditioning. J Anesth (2007) 1.12
Cardiac sulfonylurea receptor short form-based channels confer a glibenclamide-insensitive KATP activity. J Mol Cell Cardiol (2007) 1.12
Molecular identification and functional characterization of a mitochondrial sulfonylurea receptor 2 splice variant generated by intraexonic splicing. Circ Res (2009) 1.12
The KATP channel opener diazoxide protects cardiac myocytes during metabolic inhibition without causing mitochondrial depolarization or flavoprotein oxidation. Br J Pharmacol (2001) 1.12
Mechanisms of neuroprotection during ischemic preconditioning: lessons from anoxic tolerance. Comp Biochem Physiol A Mol Integr Physiol (2006) 1.11
Retracted Connexin 43 acts as a cytoprotective mediator of signal transduction by stimulating mitochondrial KATP channels in mouse cardiomyocytes. J Clin Invest (2010) 1.10
Oxygen-conserving reflexes of the brain: the current molecular knowledge. J Cell Mol Med (2009) 1.08
Mitochondrial potassium ATP channels and retinal ischemic preconditioning. Invest Ophthalmol Vis Sci (2006) 1.08
Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br J Pharmacol (2007) 1.04
Fluctuations in mitochondrial membrane potential in single isolated brain mitochondria: modulation by adenine nucleotides and Ca2+. Biophys J (2004) 1.04
A novel mitochondrial K(ATP) channel assay. Circ Res (2010) 1.00
Cytoplasmic terminus domains of Kir6.x confer different nucleotide-dependent gating on the ATP-sensitive K+ channel. J Physiol (1998) 1.00
The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease. J Alzheimers Dis (2010) 1.00
Physiological consequences of complex II inhibition for aging, disease, and the mKATP channel. Biochim Biophys Acta (2013) 0.99
Ion channels and membrane rafts in apoptosis. Pflugers Arch (2004) 0.99
Physiology of potassium channels in the inner membrane of mitochondria. Pflugers Arch (2011) 0.99
Delayed neuronal preconditioning by NS1619 is independent of calcium activated potassium channels. J Neurochem (2007) 0.97
Hydrogen sulfide dilates cerebral arterioles by activating smooth muscle cell plasma membrane KATP channels. Am J Physiol Heart Circ Physiol (2011) 0.96
Properties of the mitochondrial peptide-sensitive cationic channel studied in planar bilayers and patches of giant liposomes. Biophys J (1992) 0.95
Multiplicity of effectors of the cardioprotective agent, diazoxide. Pharmacol Ther (2013) 0.95
Redox control of cardiac excitability. Antioxid Redox Signal (2012) 0.94
Regulation of ion channels by pyridine nucleotides. Circ Res (2013) 0.94
The role of ATP-sensitive potassium channels in cellular function and protection in the cardiovascular system. Br J Pharmacol (2014) 0.94
Mechanisms of actions of hydrogen sulphide on rat distal colonic epithelium. Br J Pharmacol (2011) 0.92
Mitochondria are sources of metabolic sink and arrhythmias. Pharmacol Ther (2011) 0.92
Response of isolated rat liver mitochondria to variation of external osmolarity in KCl medium: regulation of matrix volume and oxidative phosphorylation. J Bioenerg Biomembr (1997) 0.92
Calcium ions regulate K⁺ uptake into brain mitochondria: the evidence for a novel potassium channel. Int J Mol Sci (2009) 0.91
Mitochondrial ATP-sensitive K+ channels, protectors of the heart. J Physiol (2010) 0.91
KATP channel openers have opposite effects on mitochondrial respiration under different energetic conditions. J Cardiovasc Pharmacol (2008) 0.91
Ca2+ dynamics in the mitochondria - state of the art. J Mol Cell Cardiol (2011) 0.90
The role of mitochondrial K(ATP) channels in antiarrhythmic effects of ischaemic preconditioning in dogs. Br J Pharmacol (2002) 0.89
Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection. Curr Med Chem (2009) 0.89
The intracellular localization and function of the ATP-sensitive K+ channel subunit Kir6.1. J Membr Biol (2010) 0.89
Mitochondrial ATP-sensitive potassium channel activity and hypoxic preconditioning are independent of an inwardly rectifying potassium channel subunit in Caenorhabditis elegans. FEBS Lett (2012) 0.89
ATP-sensitive K+-channel subunits on the mitochondria and endoplasmic reticulum of rat cardiomyocytes. J Histochem Cytochem (2005) 0.88
Sulfonylurea receptor 1 subunits of ATP-sensitive potassium channels and myocardial ischemia/reperfusion injury. Trends Cardiovasc Med (2009) 0.88
Mitochondria: the missing link between preconditioning and neuroprotection. J Alzheimers Dis (2010) 0.88
Mitochondrial cytochrome c release may occur by volume-dependent mechanisms not involving permeability transition. Biochem J (2004) 0.88
Nitrite as a mediator of ischemic preconditioning and cytoprotection. Nitric Oxide (2011) 0.88
Trypanosome Letm1 protein is essential for mitochondrial potassium homeostasis. J Biol Chem (2013) 0.88
Regulation of the ATP-sensitive potassium channel subunit, Kir6.2, by a Ca2+-dependent protein kinase C. J Biol Chem (2011) 0.87
Lack of manifestations of diazoxide/5-hydroxydecanoate-sensitive KATP channel in rat brain nonsynaptosomal mitochondria. J Physiol (2005) 0.87
Adenine nucleotide translocase mediates the K(ATP)-channel-openers-induced proton and potassium flux to the mitochondrial matrix. J Bioenerg Biomembr (2003) 0.86
Connexin 43 impacts on mitochondrial potassium uptake. Front Pharmacol (2013) 0.86
Opening of mitochondrial K+ channels increases ischemic ATP levels by preventing hydrolysis. J Bioenerg Biomembr (2002) 0.85
Regulated production of free radicals by the mitochondrial electron transport chain: Cardiac ischemic preconditioning. Adv Drug Deliv Rev (2009) 0.85
Water and ion channels: crucial in the initiation and progression of apoptosis in central nervous system? Curr Neuropharmacol (2008) 0.85
Mitochondrial ion channels as therapeutic targets. FEBS Lett (2010) 0.85
Quinine inhibits mitochondrial ATP-regulated potassium channel from bovine heart. J Membr Biol (2004) 0.84
Diazoxide attenuates ischemia/reperfusion injury via upregulation of heme oxygenase-1 after liver transplantation in rats. World J Gastroenterol (2012) 0.84
Testosterone protects female embryonic heart H9c2 cells against severe metabolic stress by activating estrogen receptors and up-regulating IES SUR2B. Int J Biochem Cell Biol (2012) 0.84
Preservation of mitochondrial function by diazoxide during sustained ischaemia in the rat heart. Br J Pharmacol (2000) 0.84
Glibenclamide depletes ATP in renal proximal tubular cells by interfering with mitochondrial metabolism. Br J Pharmacol (2005) 0.84
Neuroprotective role of ATP-sensitive potassium channels in cerebral ischemia. Acta Pharmacol Sin (2012) 0.84
Mitochondrial preconditioning: a potential neuroprotective strategy. Front Aging Neurosci (2010) 0.83
Methyl pyruvate stimulates pancreatic beta-cells by a direct effect on KATP channels, and not as a mitochondrial substrate. Biochem J (2002) 0.83
Diabetes mellitus reduces the function and expression of ATP-dependent K⁺ channels in cardiac mitochondria. Life Sci (2012) 0.83
The C. elegans mitochondrial K+(ATP) channel: a potential target for preconditioning. Biochem Biophys Res Commun (2008) 0.83
Targeted expression of Kir6.2 in mitochondria confers protection against hypoxic stress. J Physiol (2006) 0.82
Antidiabetic sulphonylureas activate mitochondrial permeability transition in rat skeletal muscle. Br J Pharmacol (2005) 0.82
KATP Channels in the Cardiovascular System. Physiol Rev (2016) 0.82
Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells. Virchows Arch (2007) 0.82
Genome-Wide Expression Profiling of Anoxia/Reoxygenation in Rat Cardiomyocytes Uncovers the Role of MitoKATP in Energy Homeostasis. Oxid Med Cell Longev (2015) 0.82
Modulation of myocardial mitochondrial mechanisms during severe polymicrobial sepsis in the rat. PLoS One (2011) 0.81
K(ATP) channel opener diazoxide prevents neurodegeneration: a new mechanism of action via antioxidative pathway activation. PLoS One (2013) 0.81
Nicardipine-sensitive Na+-mediated single channel currents in guinea-pig sinoatrial node pacemaker cells. J Physiol (1999) 0.81
Pharmacological evidence for a KATP channel in renin-secreting cells from rat kidney. J Physiol (1999) 0.81
Modulation of slow waves by hyperpolarization with potassium channel openers in antral smooth muscle of the guinea-pig stomach. J Physiol (2003) 0.81
Immediate neuronal preconditioning by NS1619. Brain Res (2009) 0.80
Disrupting KATP channels diminishes the estrogen-mediated protection in female mutant mice during ischemia-reperfusion. Clin Proteomics (2014) 0.80
Conventional, but not remote ischemic preconditioning, reduces iNOS transcription in liver ischemia/reperfusion. World J Gastroenterol (2014) 0.80
ATP accelerates respiration of mitochondria from rat lung and suppresses their release of hydrogen peroxide. J Bioenerg Biomembr (2005) 0.80
New properties of mitochondrial ATP-regulated potassium channels. J Bioenerg Biomembr (2008) 0.80
Fatty acids induce chloride permeation in rat liver mitochondria by activation of the inner membrane anion channel (IMAC). J Bioenerg Biomembr (2004) 0.79
Crocetin reduces activation of hepatic apoptotic pathways and improves survival in experimental hemorrhagic shock. JPEN J Parenter Enteral Nutr (2011) 0.79
Label-free cell phenotypic profiling decodes the composition and signaling of an endogenous ATP-sensitive potassium channel. Sci Rep (2014) 0.79
Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta (2000) 5.39
Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet (1992) 5.14
Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci U S A (1992) 4.13
Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (1999) 3.22
Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion. J Biol Chem (1999) 3.06
A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem (1986) 2.65
Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease. Gastroenterology (1996) 2.59
TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem (2001) 2.58
Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem (1992) 2.43
Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem (1999) 2.33
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17
Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem (1990) 2.13
Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry (1990) 2.06
The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res (1998) 1.94
Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol (1998) 1.90
Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut (1997) 1.89
Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption. Endocrinology (1998) 1.75
Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab Invest (1992) 1.74
Degradation of chromosomal DNA during apoptosis. Cell Death Differ (2003) 1.73
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst (1999) 1.71
Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis (1989) 1.71
Degradation of interleukin 1beta by matrix metalloproteinases. J Biol Chem (1996) 1.69
Successful treatment of refractory bronchorrhea by inhaled indomethacin in two patients with bronchioloalveolar carcinoma. Chest (1999) 1.67
Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer (1987) 1.60
p53 in chronic myelogenous leukemia in acute phase. Proc Natl Acad Sci U S A (1991) 1.56
Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res (1992) 1.55
The complete primary structure of human matrix metalloproteinase-3. Identity with stromelysin. J Biol Chem (1988) 1.54
Distribution of dendrites of mitral, displaced mitral, tufted, and granule cells in the rabbit olfactory bulb. J Comp Neurol (1983) 1.53
Human plasma kallikrein. A rapid purification method with high yield. Biochem J (1981) 1.53
Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo. Arch Int Pharmacodyn Ther (1992) 1.51
A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res (1985) 1.51
The crystal structure of manganese peroxidase from Phanerochaete chrysosporium at 2.06-A resolution. J Biol Chem (1994) 1.49
Detection of 12 germ-line mutations in the adenomatous polyposis coli gene by polymerase chain reaction. Gastroenterology (1993) 1.49
Insular cortex and neuropsychiatric disorders: a review of recent literature. Eur Psychiatry (2007) 1.48
The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res (1992) 1.47
Urokinase plasminogen activator and gelatinases are associated with membrane vesicles shed by human HT1080 fibrosarcoma cells. J Biol Chem (1997) 1.45
GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay. FEBS Lett (1998) 1.45
Geranylgeranylacetone induces heat shock proteins in cultured guinea pig gastric mucosal cells and rat gastric mucosa. Gastroenterology (1996) 1.45
Structural properties of matrix metalloproteinases. Cell Mol Life Sci (1999) 1.43
Evaluation of aspartic acid racemization ratios in the human femur for age estimation. J Forensic Sci (1998) 1.43
Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J Clin Invest (1989) 1.42
Purification of an endogenous activator of procollagenase from rabbit synovial fibroblast culture medium. J Biol Chem (1983) 1.42
Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem (1995) 1.42
Frequency and types of point mutation at the 12th codon of the c-Ki-ras gene found in pancreatic cancers from Japanese patients. Jpn J Cancer Res (1989) 1.40
Inactivation of tissue inhibitor of metalloproteinases by neutrophil elastase and other serine proteinases. FEBS Lett (1988) 1.39
Odontogenic myxoma of maxillary sinus: CT and MR-pathologic correlation. Eur J Radiol (2001) 1.39
Glutathione depletion inhibits oxidant-induced activation of nuclear factor-kappa B, AP-1, and c-Jun/ATF-2 in cultured guinea-pig gastric epithelial cells. J Gastroenterol (1998) 1.39
A case of recurrent ameloblastoma developing in an autogenous iliac bone graft 20 years after the initial treatment. Dentomaxillofac Radiol (2006) 1.39
Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol (1999) 1.38
Transcatheter arterial embolization in unresectable hepatocellular carcinoma. Cardiovasc Intervent Radiol (1990) 1.37
Molecular cloning of the cDNA for stimulatory GDP/GTP exchange protein for smg p21s (ras p21-like small GTP-binding proteins) and characterization of stimulatory GDP/GTP exchange protein. Mol Cell Biol (1991) 1.36
Hydrolysis of triple-helical collagen peptide models by matrix metalloproteinases. J Biol Chem (2000) 1.35
Selective localization of matrix metalloproteinase 9, beta1 integrins, and human lymphocyte antigen class I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res (1998) 1.33
Identification of the (183)RWTNNFREY(191) region as a critical segment of matrix metalloproteinase 1 for the expression of collagenolytic activity. J Biol Chem (2000) 1.32
Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J Biol Chem (1994) 1.32
Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun (2001) 1.32
The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem J (1988) 1.30
The trajectory of mitral cell axons in the rabbit olfactory cortex revealed by intracellular HRP injection. J Comp Neurol (1984) 1.30
An improved assay for proteases and polysaccharidases employing a cartilage proteoglycan substrate entrapped in polyacrylamide particles. Anal Biochem (1980) 1.29
Continuously recording fluorescent assays optimized for five human matrix metalloproteinases. Anal Biochem (1991) 1.28
Does prolonged breastfeeding adversely affect a child's nutritional status? Lancet (1988) 1.27
Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem J (1992) 1.27
Bone metastasis in hepatocellular carcinoma. Cancer (1985) 1.26
Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists. J Med Chem (1988) 1.25
Balloon-occluded retrograde transvenous obliteration for gastric varices: a feasibility study. Cardiovasc Intervent Radiol (1998) 1.24
Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase. Arch Biochem Biophys (1988) 1.24
Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb (1994) 1.23
Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility. Kidney Int (1997) 1.23
A precursor form of latent collagenase produced in a cell-free system with mRNA from rabbit synovial cells. J Biol Chem (1981) 1.22
A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem (1999) 1.22
Space shuttle flight (STS-90) enhances degradation of rat myosin heavy chain in association with activation of ubiquitin-proteasome pathway. FASEB J (2001) 1.21
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
Measurement of deoxyribonuclease I activity in human tissues and body fluids by a single radial enzyme-diffusion method. Clin Chem (1993) 1.21
Biosynthesis and secretion of procollagenase by rabbit synovial fibroblasts. Inhibition of procollagenase secretion by monensin and evidence for glycosylation of procollagenase. Biochem J (1983) 1.21
Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph-node syndrome. Lancet (1973) 1.20
Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem (1995) 1.20
Purification of the neutral proteoglycan-degrading metalloproteinase from human articular cartilage tissue and its identification as stromelysin matrix metalloproteinase-3. Biochem J (1989) 1.20
Opioid-induced second window of cardioprotection: potential role of mitochondrial KATP channels. Circ Res (1999) 1.20
Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum (1998) 1.19
Cancer resistance genes in mice: models for the study of tumour modifiers. Trends Genet (1998) 1.19
Kinetic analysis of matrix metalloproteinase activity using fluorogenic triple-helical substrates. Biochemistry (2001) 1.19
Schwannoma of the upper lip: ultrasound, CT, and MRI findings. J Oral Maxillofac Surg (2000) 1.19
Insights into MMP-TIMP interactions. Ann N Y Acad Sci (1999) 1.18
Gallbladder infarction after hepatic artery embolization. AJR Am J Roentgenol (1985) 1.18
Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse uterus during the peri-implantation period. Dev Genet (1997) 1.18
Plasma membrane-bound tissue inhibitor of metalloproteinases (TIMP)-2 specifically inhibits matrix metalloproteinase 2 (gelatinase A) activated on the cell surface. J Biol Chem (1998) 1.17
Isolation of the gene coding for the alpha subunit of the human high affinity IgE receptor. Nucleic Acids Res (1988) 1.16
Folding and characterization of the amino-terminal domain of human tissue inhibitor of metalloproteinases-1 (TIMP-1) expressed at high yield in E. coli. FEBS Lett (1996) 1.16
Genetic diagnosis identifies occult lymph node metastases undetectable by the histopathological method. Cancer Res (1994) 1.16
Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. Am J Physiol (1997) 1.14
Steps involved in activation of the complex of pro-matrix metalloproteinase 2 (progelatinase A) and tissue inhibitor of metalloproteinases (TIMP)-2 by 4-aminophenylmercuric acetate. Biochem J (1995) 1.14
Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2 and 3 in fibroblasts. Br J Cancer (1995) 1.14
Radiographic examination of mesiodens and their associated complications. Dentomaxillofac Radiol (2004) 1.14
Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet-derived growth factor. Atherosclerosis (1991) 1.13
The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J Biol Chem (1997) 1.13
Identification of plasma kallikrein as an activator of latent collagenase in rheumatoid synovial fluid. Biochim Biophys Acta (1982) 1.13
Toll-like receptor 4 regulates gastric pit cell responses to Helicobacter pylori infection. J Med Invest (2001) 1.12
Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels. J Pharmacol Exp Ther (2000) 1.11
smg/rap1/Krev-1 p21s inhibit the signal pathway to the c-fos promoter/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells. Oncogene (1992) 1.10